Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 505

1.

Obstetrics knowledge and skills training as a catalyst for change.

Pattinson RC, Bergh AM, Makin J, Pillay Y, Moodley J, Madaj B, Ameh C, Van den Broek N.

S Afr Med J. 2018 Aug 28;108(9):748-755. doi: 10.7196/SAMJ.2018.v108i9.13073.

2.

The Proteome of Prostate Cancer Bone Metastasis Reveals Heterogeneity with Prognostic Implications.

Iglesias-Gato D, Thysell E, Tyanova S, Crnalic S, Santos A, Lima TS, Geiger T, Cox J, Widmark A, Bergh A, Mann M, Flores-Morales A, Wikström P.

Clin Cancer Res. 2018 Jul 24. doi: 10.1158/1078-0432.CCR-18-1229. [Epub ahead of print]

PMID:
30042207
3.

Development of a prediction model for late urinary incontinence, hematuria, pain and voiding frequency among irradiated prostate cancer patients.

Schaake W, van der Schaaf A, van Dijk LV, van den Bergh ACM, Langendijk JA.

PLoS One. 2018 Jul 17;13(7):e0197757. doi: 10.1371/journal.pone.0197757. eCollection 2018.

4.

Risk of Solid Cancer After Treatment of Testicular Germ Cell Cancer in the Platinum Era.

Groot HJ, Lubberts S, de Wit R, Witjes JA, Kerst JM, de Jong IJ, Groenewegen G, van den Eertwegh AJM, Poortmans PM, Klümpen HJ, van den Berg HA, Smilde TJ, Vanneste BGL, Aarts MJ, Incrocci L, van den Bergh ACM, Jóźwiak K, van den Belt-Dusebout AW, Horenblas S, Gietema JA, van Leeuwen FE, Schaapveld M.

J Clin Oncol. 2018 Aug 20;36(24):2504-2513. doi: 10.1200/JCO.2017.77.4174. Epub 2018 Jul 10.

PMID:
29989856
5.

Preclinical Bioavailability Strategy for Decisions on Clinical Drug Formulation Development: An In Depth Analysis.

Van den Bergh A, Van Hemelryck S, Bevernage J, Van Peer A, Brewster M, Mackie C, Mannaert E.

Mol Pharm. 2018 Jul 2;15(7):2633-2645. doi: 10.1021/acs.molpharmaceut.8b00172. Epub 2018 Jun 11.

PMID:
29799758
6.

Report on an international workshop on kangaroo mother care: lessons learned and a vision for the future.

Cattaneo A, Amani A, Charpak N, De Leon-Mendoza S, Moxon S, Nimbalkar S, Tamburlini G, Villegas J, Bergh AM.

BMC Pregnancy Childbirth. 2018 May 16;18(1):170. doi: 10.1186/s12884-018-1819-9.

7.

'I thought they were going to handle me like a queen but they didn't': A qualitative study exploring the quality of care provided to women at the time of birth.

Lambert J, Etsane E, Bergh AM, Pattinson R, van den Broek N.

Midwifery. 2018 Jul;62:256-263. doi: 10.1016/j.midw.2018.04.007. Epub 2018 Apr 22.

8.

Bone Cell Activity in Clinical Prostate Cancer Bone Metastasis and Its Inverse Relation to Tumor Cell Androgen Receptor Activity.

Nordstrand A, Bovinder Ylitalo E, Thysell E, Jernberg E, Crnalic S, Widmark A, Bergh A, Lerner UH, Wikström P.

Int J Mol Sci. 2018 Apr 18;19(4). pii: E1223. doi: 10.3390/ijms19041223.

9.

Lymphocytes eject interferogenic mitochondrial DNA webs in response to CpG and non-CpG oligodeoxynucleotides of class C.

Ingelsson B, Söderberg D, Strid T, Söderberg A, Bergh AC, Loitto V, Lotfi K, Segelmark M, Spyrou G, Rosén A.

Proc Natl Acad Sci U S A. 2018 Jan 16;115(3):E478-E487. doi: 10.1073/pnas.1711950115. Epub 2018 Jan 2.

10.

Prostate tumors downregulate microseminoprotein-beta (MSMB) in the surrounding benign prostate epithelium and this response is associated with tumor aggressiveness.

Bergström SH, Järemo H, Nilsson M, Adamo HH, Bergh A.

Prostate. 2018 Mar;78(4):257-265. doi: 10.1002/pros.23466. Epub 2017 Dec 18.

PMID:
29250809
11.

Pro-invasive properties of Snail1 are regulated by sumoylation in response to TGFβ stimulation in cancer.

Gudey SK, Sundar R, Heldin CH, Bergh A, Landström M.

Oncotarget. 2017 Aug 9;8(58):97703-97726. doi: 10.18632/oncotarget.20097. eCollection 2017 Nov 17.

12.

A Systems Approach to Prostate Cancer Classification-Letter.

Thysell E, Ylitalo EB, Jernberg E, Bergh A, Wikström P.

Cancer Res. 2017 Dec 15;77(24):7131-7132. doi: 10.1158/0008-5472.CAN-16-3231. Epub 2017 Dec 6. No abstract available.

PMID:
29212852
13.

Vertical head and pelvic movement symmetry at the trot in dogs with induced supporting limb lameness.

Gómez Álvarez CB, Gustås P, Bergh A, Rhodin M.

Vet J. 2017 Nov;229:13-18. doi: 10.1016/j.tvjl.2017.10.011. Epub 2017 Oct 20.

PMID:
29183568
14.

It does matter where you come from: mothers' experiences of childbirth in midwife obstetric units, Tshwane, South Africa.

Oosthuizen SJ, Bergh AM, Pattinson RC, Grimbeek J.

Reprod Health. 2017 Nov 16;14(1):151. doi: 10.1186/s12978-017-0411-5.

15.

Distributed decision making in action: diagnostic imaging investigations within the bigger picture.

Makanjee CR, Bergh AM, Hoffmann WA.

J Med Radiat Sci. 2018 Mar;65(1):5-12. doi: 10.1002/jmrs.250. Epub 2017 Nov 11.

16.

Highly aggressive rat prostate tumors rapidly precondition regional lymph nodes for subsequent metastatic growth.

Strömvall K, Lundholm M, Thysell E, Bergh A, Halin Bergström S.

PLoS One. 2017 Oct 26;12(10):e0187086. doi: 10.1371/journal.pone.0187086. eCollection 2017.

17.

Prostate Cancer Detection with a Tactile Resonance Sensor-Measurement Considerations and Clinical Setup.

Åstrand AP, Andersson BM, Jalkanen V, Ljungberg B, Bergh A, Lindahl OA.

Sensors (Basel). 2017 Oct 26;17(11). pii: E2453. doi: 10.3390/s17112453.

18.

Association Between Lead Time and Prostate Cancer Grade: Evidence of Grade Progression from Long-term Follow-up of Large Population-based Cohorts Not Subject to Prostate-specific Antigen Screening.

Assel M, Dahlin A, Ulmert D, Bergh A, Stattin P, Lilja H, Vickers AJ.

Eur Urol. 2018 Jun;73(6):961-967. doi: 10.1016/j.eururo.2017.10.004. Epub 2017 Oct 21.

PMID:
29066048
19.

Comparing subjective and objective evaluation of show jumping competition and warm-up arena surfaces.

Hernlund E, Egenvall A, Hobbs SJ, Peterson ML, Northrop AJ, Bergh A, Martin JH, Roepstorff L.

Vet J. 2017 Sep;227:49-57. doi: 10.1016/j.tvjl.2017.09.001. Epub 2017 Sep 11.

20.

Clinical relevance of androgen receptor alterations in prostate cancer.

Jernberg E, Bergh A, Wikström P.

Endocr Connect. 2017 Nov;6(8):R146-R161. doi: 10.1530/EC-17-0118. Review.

21.

Reduced number of CD169+ macrophages in pre-metastatic regional lymph nodes is associated with subsequent metastatic disease in an animal model and with poor outcome in prostate cancer patients.

Strömvall K, Sundkvist K, Ljungberg B, Halin Bergström S, Bergh A.

Prostate. 2017 Nov;77(15):1468-1477. doi: 10.1002/pros.23407. Epub 2017 Sep 7.

22.

T-Time: A data repository of T cell and calcium release-activated calcium channel activation imagery.

Arbuckle C, Greenberg M, Bergh A, German R, Sirago N, Linstead E.

BMC Res Notes. 2017 Aug 15;10(1):408. doi: 10.1186/s13104-017-2739-x.

23.

Differences in Trial and Real-world Populations in the Dutch Castration-resistant Prostate Cancer Registry.

Westgeest HM, Uyl-de Groot CA, van Moorselaar RJA, de Wit R, van den Bergh ACM, Coenen JLLM, Beerlage HP, Hendriks MP, Bos MMEM, van den Berg P, van de Wouw AJ, Spermon R, Boerma MO, Geenen MM, Tick LW, Polee MB, Bloemendal HJ, Cordia I, Peters FPJ, de Vos AI, van den Bosch J, van den Eertwegh AJM, Gerritsen WR.

Eur Urol Focus. 2016 Oct 13. pii: S2405-4569(16)30145-6. doi: 10.1016/j.euf.2016.09.008. [Epub ahead of print]

PMID:
28753794
24.

TGF-β promotes PI3K-AKT signaling and prostate cancer cell migration through the TRAF6-mediated ubiquitylation of p85α.

Hamidi A, Song J, Thakur N, Itoh S, Marcusson A, Bergh A, Heldin CH, Landström M.

Sci Signal. 2017 Jul 4;10(486). pii: eaal4186. doi: 10.1126/scisignal.aal4186.

PMID:
28676490
25.

A Survey of Female Sexual Functioning in the General Dutch Population.

Lammerink EAG, de Bock GH, Pascal A, van Beek AP, van den Bergh ACM, Sattler MGA, Mourits MJE.

J Sex Med. 2017 Jul;14(7):937-949. doi: 10.1016/j.jsxm.2017.04.676.

PMID:
28673436
27.

U-CAN: a prospective longitudinal collection of biomaterials and clinical information from adult cancer patients in Sweden.

Glimelius B, Melin B, Enblad G, Alafuzoff I, Beskow A, Ahlström H, Bill-Axelson A, Birgisson H, Björ O, Edqvist PH, Hansson T, Helleday T, Hellman P, Henriksson K, Hesselager G, Hultdin M, Häggman M, Höglund M, Jonsson H, Larsson C, Lindman H, Ljuslinder I, Mindus S, Nygren P, Pontén F, Riklund K, Rosenquist R, Sandin F, Schwenk JM, Stenling R, Stålberg K, Stålberg P, Sundström C, Thellenberg Karlsson C, Westermark B, Bergh A, Claesson-Welsh L, Palmqvist R, Sjöblom T.

Acta Oncol. 2018 Feb;57(2):187-194. doi: 10.1080/0284186X.2017.1337926. Epub 2017 Jun 20.

PMID:
28631533
28.

Metastatic spinal cord compression as the first sign of malignancy.

Wänman J, Grabowski P, Nyström H, Gustafsson P, Bergh A, Widmark A, Crnalic S.

Acta Orthop. 2017 Aug;88(4):457-462. doi: 10.1080/17453674.2017.1319179. Epub 2017 May 11.

29.

Aggressive rat prostate tumors reprogram the benign parts of the prostate and regional lymph nodes prior to metastasis.

Strömvall K, Thysell E, Halin Bergström S, Bergh A.

PLoS One. 2017 May 4;12(5):e0176679. doi: 10.1371/journal.pone.0176679. eCollection 2017.

30.

Inhibition of the insulin-like growth factor-1 receptor potentiates acute effects of castration in a rat model for prostate cancer growth in bone.

Nordstrand A, Bergström SH, Thysell E, Bovinder-Ylitalo E, Lerner UH, Widmark A, Bergh A, Wikström P.

Clin Exp Metastasis. 2017 Apr;34(3-4):261-271. doi: 10.1007/s10585-017-9848-8. Epub 2017 Apr 26.

31.

Inertial sensor-based system for lameness detection in trotting dogs with induced lameness.

Rhodin M, Bergh A, Gustås P, Gómez Álvarez CB.

Vet J. 2017 Apr;222:54-59. doi: 10.1016/j.tvjl.2017.02.004. Epub 2017 Feb 10.

32.

Self-Management Support Needs of Patients with Chronic Diseases in a South African Township: A Qualitative Study.

Dube L, Rendall-Mkosi K, Van den Broucke S, Bergh AM, Mafutha NG.

J Community Health Nurs. 2017 Jan-Mar;34(1):21-31. doi: 10.1080/07370016.2017.1260983.

PMID:
28156143
33.

High levels of the AR-V7 Splice Variant and Co-Amplification of the Golgi Protein Coding YIPF6 in AR Amplified Prostate Cancer Bone Metastases.

Djusberg E, Jernberg E, Thysell E, Golovleva I, Lundberg P, Crnalic S, Widmark A, Bergh A, Brattsand M, Wikström P.

Prostate. 2017 May;77(6):625-638. doi: 10.1002/pros.23307. Epub 2017 Feb 1.

PMID:
28144969
35.

High Caveolin-1 Expression in Tumor Stroma Is Associated with a Favourable Outcome in Prostate Cancer Patients Managed by Watchful Waiting.

Hammarsten P, Dahl Scherdin T, Hägglöf C, Andersson P, Wikström P, Stattin P, Egevad L, Granfors T, Bergh A.

PLoS One. 2016 Oct 20;11(10):e0164016. doi: 10.1371/journal.pone.0164016. eCollection 2016.

36.

Extracellular Vesicles from Metastatic Rat Prostate Tumors Prime the Normal Prostate Tissue to Facilitate Tumor Growth.

Halin Bergström S, Hägglöf C, Thysell E, Bergh A, Wikström P, Lundholm M.

Sci Rep. 2016 Aug 23;6:31805. doi: 10.1038/srep31805.

37.

Subgroups of Castration-resistant Prostate Cancer Bone Metastases Defined Through an Inverse Relationship Between Androgen Receptor Activity and Immune Response.

Ylitalo EB, Thysell E, Jernberg E, Lundholm M, Crnalic S, Egevad L, Stattin P, Widmark A, Bergh A, Wikström P.

Eur Urol. 2017 May;71(5):776-787. doi: 10.1016/j.eururo.2016.07.033. Epub 2016 Aug 3.

38.
39.

Extratumoral Heme Oxygenase-1 (HO-1) Expressing Macrophages Likely Promote Primary and Metastatic Prostate Tumor Growth.

Halin Bergström S, Nilsson M, Adamo H, Thysell E, Jernberg E, Stattin P, Widmark A, Wikström P, Bergh A.

PLoS One. 2016 Jun 9;11(6):e0157280. doi: 10.1371/journal.pone.0157280. eCollection 2016.

40.

Normal tissue complication probability (NTCP) models for late rectal bleeding, stool frequency and fecal incontinence after radiotherapy in prostate cancer patients.

Schaake W, van der Schaaf A, van Dijk LV, Bongaerts AH, van den Bergh AC, Langendijk JA.

Radiother Oncol. 2016 Jun;119(3):381-7. doi: 10.1016/j.radonc.2016.04.005. Epub 2016 May 3.

PMID:
27157889
41.

Rat Prostate Tumor Cells Progress in the Bone Microenvironment to a Highly Aggressive Phenotype.

Bergström SH, Rudolfsson SH, Bergh A.

Neoplasia. 2016 Mar;18(3):152-61. doi: 10.1016/j.neo.2016.01.007.

42.

Short Androgen Suppression and Radiation Dose Escalation for Intermediate- and High-Risk Localized Prostate Cancer: Results of EORTC Trial 22991.

Bolla M, Maingon P, Carrie C, Villa S, Kitsios P, Poortmans PM, Sundar S, van der Steen-Banasik EM, Armstrong J, Bosset JF, Herrera FG, Pieters B, Slot A, Bahl A, Ben-Yosef R, Boehmer D, Scrase C, Renard L, Shash E, Coens C, van den Bergh AC, Collette L.

J Clin Oncol. 2016 May 20;34(15):1748-56. doi: 10.1200/JCO.2015.64.8055. Epub 2016 Mar 14.

PMID:
26976418
43.

Clinician perceptions and patient experiences of antiretroviral treatment integration in primary health care clinics, Tshwane, South Africa.

Mathibe MD, Hendricks SJ, Bergh AM.

Curationis. 2015 Oct 2;38(1). doi: 10.4102/curationis.v38i1.1489.

44.

The three waves in implementation of facility-based kangaroo mother care: a multi-country case study from Asia.

Bergh AM, de Graft-Johnson J, Khadka N, Om'Iniabohs A, Udani R, Pratomo H, De Leon-Mendoza S.

BMC Int Health Hum Rights. 2016 Jan 27;16:4. doi: 10.1186/s12914-016-0080-4.

45.

Inhibition of Lysyl Oxidase and Lysyl Oxidase-Like Enzymes Has Tumour-Promoting and Tumour-Suppressing Roles in Experimental Prostate Cancer.

Nilsson M, Adamo H, Bergh A, Halin Bergström S.

Sci Rep. 2016 Jan 25;6:19608. doi: 10.1038/srep19608.

46.

Taking kangaroo mother care forward in South Africa: The role of district clinical specialist teams.

Feucht UD, van Rooyen E, Skhosana R, Bergh AM.

S Afr Med J. 2015 Nov 20;106(1):49-52. doi: 10.7196/SAMJ.2016.v106i1.10149. Review.

PMID:
26792305
47.

The Proteome of Primary Prostate Cancer.

Iglesias-Gato D, Wikström P, Tyanova S, Lavallee C, Thysell E, Carlsson J, Hägglöf C, Cox J, Andrén O, Stattin P, Egevad L, Widmark A, Bjartell A, Collins CC, Bergh A, Geiger T, Mann M, Flores-Morales A.

Eur Urol. 2016 May;69(5):942-52. doi: 10.1016/j.eururo.2015.10.053. Epub 2015 Dec 2.

PMID:
26651926
48.

APPL proteins promote TGFβ-induced nuclear transport of the TGFβ type I receptor intracellular domain.

Song J, Mu Y, Li C, Bergh A, Miaczynska M, Heldin CH, Landström M.

Oncotarget. 2016 Jan 5;7(1):279-92. doi: 10.18632/oncotarget.6346.

49.

Adaptive (TINT) Changes in the Tumor Bearing Organ Are Related to Prostate Tumor Size and Aggressiveness.

Adamo HH, Strömvall K, Nilsson M, Halin Bergström S, Bergh A.

PLoS One. 2015 Nov 4;10(11):e0141601. doi: 10.1371/journal.pone.0141601. eCollection 2015.

50.

Secreted Factors from Colorectal and Prostate Cancer Cells Skew the Immune Response in Opposite Directions.

Lundholm M, Hägglöf C, Wikberg ML, Stattin P, Egevad L, Bergh A, Wikström P, Palmqvist R, Edin S.

Sci Rep. 2015 Oct 27;5:15651. doi: 10.1038/srep15651.

Supplemental Content

Support Center